Sonoma Pharmaceuticals, Inc.
General ticker "SNOA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $4.6M (TTM average)
Sonoma Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 38.5%.
Estimated limits based on current volatility of 4.0%: low 3.18$, high 3.44$
Factors to consider:
- Total employees count: 69 as of 2007
- Top business risk factors: Regulatory and compliance, Geopolitical risks, Market acceptance, Manufacturing risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [1.64$, 5.08$]
- 2026-03-31 to 2027-03-31 estimated range: [1.41$, 4.31$]
Financial Metrics affecting the SNOA estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 18.93 < Shareholder equity ratio, % of 32.21 <= 41.86
- Negative: Operating cash flow per share per price, % of -2.30 <= 0.33
- Positive: -4.48 < Investing cash flow per share per price, % of -2.09
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term SNOA quotes
Long-term SNOA plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $13.27MM | $12.73MM | $14.29MM |
| Operating Expenses | $17.84MM | $17.44MM | $18.00MM |
| Operating Income | $-4.57MM | $-4.70MM | $-3.71MM |
| Non-Operating Income | $-0.61MM | $-0.33MM | $0.80MM |
| R&D Expense | $0.21MM | $1.87MM | $1.81MM |
| Income(Loss) | $-5.18MM | $-5.03MM | $-2.91MM |
| Taxes | $-0.03MM | $-0.20MM | $0.55MM |
| Profit(Loss)* | $-5.15MM | $-4.83MM | $-3.46MM |
| Stockholders Equity | $7.98MM | $6.14MM | $4.41MM |
| Inventory | $2.86MM | $2.72MM | $2.92MM |
| Assets | $16.23MM | $14.74MM | $13.69MM |
| Operating Cash Flow | $-6.15MM | $-2.40MM | $-0.09MM |
| Capital expenditure | $0.27MM | $0.02MM | $0.08MM |
| Investing Cash Flow | $-0.26MM | $-0.00MM | $-0.08MM |
| Financing Cash Flow | $2.49MM | $1.68MM | $3.03MM |
| Earnings Per Share** | $-15.18 | $-5.32 | $-2.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.